Procollagen type I carboxy-terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
We measured iliac bone formation rates on all surfaces after double tetracycline labeling, serum levels of type 1 procollagen carboxy-terminal extension peptide (pColl-I-C), and serum levels of total alkaline phosphatase activity (TAP) in four normal subjects and in 44 patients with various forms of metabolic bone disease. In three patients with enzymatic evidence of liver disease both biochemical serum markers were disproportionately raised. In a patient with idiopathic axial osteosclerosis serum pColl-I-C was selectively increased by more than ten-fold. In the remaining 44 subjects pColl-I-C and TAP levels correlated significantly with each other (r = 0.70) and both showed the same directional changes and broadly similar correlations with iliac bone formation rate expressed in different ways. In general, pColl-I-C levels correlated better with cancellous bone formation rates and TAP levels with cortical bone formation rates. There was a modest improvement in prediction of bone formation rate with multiple regression using both markers. In 15 patients with typical uncomplicated postmenopausal osteoporosis, neither biochemical marker, singly or jointly, correlated significantly with any expression of bone formation rate. Disadvantages to the use of pColl-I-C as a marker include a significant contribution to the serum level from type 1 collagen biosynthesis in tissues other than bone, and (probably) variable metabolic clearance. For both biochemical markers the most consistently high correlations (r = 0.77–0.79) were found with total bone formation rate for the entire biopsy core volume, which is the best estimate available from a biopsy of formation rate at the bone organ level of organization in vivo. The core volume as a referent also allows the amount of bone formed on cortical, endocortical, and cancellous surfaces to be compared. Measurement of serum pColl-I-C levels merits further study as a noninvasive index of bone metabolism. Differences between normal and abnormal subjects in the relationships between a variety of biochemical markers and a variety of histologic indices have the potential for providing insight into the pathogenesis of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,856
The Biosynthesis of Collagen and Its Disorders
Prockop, D. J., Kivirikko, K. I., Tuderman, L., & Guzman, N. A. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010104 · Cited by 1,064
Extracellular matrix biochemistry
Piez, K. A., & Reddi, A. H. (1984) · Elsevier eBooks · Cited by 1,034
SERUM BONE GLA-PROTEIN: A SPECIFIC MARKER FOR BONE FORMATION IN POSTMENOPAUSAL OSTEOPOROSIS
Brown, J. P., Malaval, L., Chapuy, M. C., Delmas, P. D., Edouard, C., & Meunier, P. J. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92506-6 · Cited by 668
DOES BREAST MILK PROTECT AGAINST SEPTICÆMIA IN THE NEWBORN ?
Winberg, J., & Wessner, G. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91836-8 · Cited by 510
Menopausal changes in bone remodeling.
Heaney, R. P., Recker, R. R., & Saville, P. D. (1978) · PubMed · Cited by 471
Radioimmunoassay for type III procollagen peptide and its application to human liver disease
ROHDE, H., VARGAS, L., ECKHARTHAHN, KALBFLEISCH, H., BRUGUERA, M., & TIMPL, R. (1979) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1979.tb00912.x · Cited by 395
Delmas, P. D., Stenner, D., Wahner, H. W., Mann, K. G., & Riggs, B. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110882 · Cited by 353
Clinical Disorders of Bone and Mineral Metabolism
FRAME, B., & MAREL, G. M. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-5-725 · Cited by 322
Collagen: Structure, function, and metabolism in normal and fibrotic tissues
Nimni, M. E. (1983) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(83)90024-0 · Cited by 266
Rosalki, S. B., & Foo, A. Y. (1984) · Clinical Chemistry · doi:10.1093/clinchem/30.7.1182 · Cited by 258
Fleischmajer, R., Timpl, R., Tuderman, L., Raisher, L., Wiestner, M., Perlish, J. S., & Graves, P. N. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7360 · Cited by 226
DIFFERENCES IN SERUM BONE GLA PROTEIN WITH AGE AND SEX
Epstein, S., Mcclintock, R., Bryce, G., Poser, J., Johnston, C., & Hui, S. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90360-x · Cited by 194
Charles, P., Poser, J. W., Mosekilde, L., & Jensen, F. T. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112234 · Cited by 162
Gundberg, C. M., Lian, J. B., Gallop, P. M., & Steinberg, J. J. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-6-1221 · Cited by 155
PARFITT, A. M., Pødenphant, J., Villanueva, A. R., & Frame, B. (1985) · Bone · doi:10.1016/8756-3282(85)90003-1 · Cited by 138
Self-citationQuantitative bone histology in 84 normal American subjects
Malluche, H. H., Meyer, W., Sherman, D., & Massry, S. G. (1982) · Calcified Tissue International · doi:10.1007/bf02411283 · Cited by 132
Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin.
Farley, J. R., Chesnut, C. H., & Baylink, D. J. (1981) · Clinical Chemistry · doi:10.1093/clinchem/27.12.2002 · Cited by 113
Serum Levels of Type I and III Procollagen Fragments in Paget's Disease of Bone*
Simon, L. S., Krane, S. M., Wortman, P. D., et al. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-1-110 · Cited by 112
Self-citationSerum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone
Delmas, P. D., Demiaux, B., Malaval, L., Chapuy, M. C., & Meunier, P. J. (1986) · Calcified Tissue International · doi:10.1007/bf02556596 · Cited by 89
Carey, D. E., Goldberg, B. D., Ratzan, S. K., et al. (1985) · Pediatric Research · doi:10.1203/00006450-198501000-00003 · Cited by 51
Serum Osteocalcin Concentrations in Paget's Disease of Bone
Wilkinson, M. R. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360140074010 · Cited by 40
Hyldstrup, L., McNair, P., JENSEN, G. F., Nielsen, H. R., & Transbøl, I. (1984) · Calcified Tissue International · doi:10.1007/bf02405383 · Cited by 22
Cited by
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Self-citationDempster, D. W., Compston, J. E., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., Recker, R. R., & Parfitt, A. M. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1805 · Cited by 2,543
Self-citationAntoniou, J., Steffen, T., Nelson, F., Winterbottom, N., Hollander, A. P., Poole, R. A., Aebi, M., & Alini, M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118884 · Cited by 1,045
ATF4 Is a Substrate of RSK2 and an Essential Regulator of Osteoblast Biology
Yang, X., Matsuda, K., Bialek, P., Jacquot, S., Masuoka, H. C., Schinke, T., Li, L., Brancorsini, S., Sassone-Corsi, P., Townes, T. M., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00344-7 · Cited by 820
Yadav, V. K., Oury, F., Suda, N., Liu, Z.-W., Gao, X.-B., Confavreux, C., Klemenhagen, K. C., Tanaka, K. F., Gingrich, J. A., Guo, X. E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.051 · Cited by 661
Metadata
- Authors
- Parfitt, A. M., Simon, L. S., Villanueva, A. R., & Krane, S. M.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1987-10-01
- Volume
- 2
- Issue
- 5
- Pages
- 427-436
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2104376589
- Cited by
- 329
- References
- 23
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.